Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
Vanadate has insulin-like activity in vitro and in vivo. To characterize the in vivo mechanism of action of vanadate, we examined meal tolerance, insulin-mediated glucose disposal, in vivo liver and muscle glycogen synthesis, and in vitro glycogen synthase activity in 90% partially pancreatectomized...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
1989
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329733/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2503545/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114250 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|